small volume parenteral market trends, small volume parenteral market scope, small volume parenteral market forecast, small volume parenteral market report, small volume parenteral market analysis, small volume parenteral market share
How big is the small volume parenteral market today, and what are its future growth expectations?
The small volume parenteral market size has grown strongly in recent years. It will grow from $177.26 billion in 2024 to $193.16 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to the rising prevalence of chronic diseases, regulatory approvals and government initiatives, pharmaceutical outsourcing trends, and globalization and expansion of pharmaceutical markets.
The small volume parenteral market size is expected to see strong growth in the next few years. It will grow to $268.53 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to the expansion of the biologics market, healthcare infrastructure development, increased hospitalization rates, regulatory approvals, a shift toward home healthcare, rising investment in healthcare, and global health crises. Major trends in the forecast period include growth in biocompatible formulations, patient-centric approaches, rise in home healthcare, advancements in manufacturing automation, expansion in therapeutic areas, and smart pump technologies.
Get Your Free Sample of The Global Small Volume Parenteral Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15925&type=smp
What have been the primary factors driving the small volume parenteral market’s growth?
The increasing number of surgeries is expected to propel the growth of the small-volume parenteral market going forward. Surgery is a medical specialty that involves using operative techniques to investigate or treat a pathological condition such as disease or injury, improve bodily function or appearance, or repair unwanted ruptured areas. The rate of surgeries is rising due to advancements in medical technology and an aging population, increasing the demand for surgical interventions. Small-volume parenteral solutions are used in surgeries to precisely administer medications, electrolytes, and nutrients directly into the bloodstream. For instance, in August 2023, according to The Aesthetic Society, a US-based organization of plastic surgery and cosmetic medicine, Americans spent more than $11.8 billion on aesthetic procedures overall, up 2% from the previous year. Therefore, the increasing number of surgeries is driving the growth of the small-volume parenteral market.
What are the key segments within the small volume parenteral market?
The small volume parenteral market covered in this report is segmented –
1) By Type: Ampules, Vials, Prefilled Syringes
2) By Dose Type: Single Dose, Multiple Dose
3) By Indication Type: Pain Management, Cancer Care, Malnourishment, Gastrointestinal Disorder Or Diarrhea, Diabetes, Other Indications
4) By Application: Local Anesthetics, Vaccines, Other Applications
5) By End User: Hospitals, Clinics, Ambulatory Surgical Center, Other End Users
Subsegments:
1) By Ampules: Glass Ampules, Plastic Ampules
2) By Vials: Glass Vials, Plastic Vials, Single-dose Vials, Multi-dose Vials
3) By Prefilled Syringes: Glass Prefilled Syringes, Plastic Prefilled Syringes
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report
Which key players are shaping the small volume parenteral market?
Major companies operating in the small volume parenteral market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Viatris Inc., Intas Pharmaceuticals Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Biocon Limited, Torrent Pharmaceuticals Ltd., Zydus Cadila, Alembic Pharmaceuticals Ltd., Wockhardt Ltd.
How will emerging trends drive the small volume parenteral market throughout the forecast period?
Major companies operating in the small volume parenteral market are focusing on developing innovative solutions, such as built-in lyophilizer, to maximize their revenues in the market. The built-in lyophilizer refers to an integrated system within the manufacturing line that freezes and dries products to create lyophilized powders, commonly used for specific parenteral drugs. For instance, in January 2022, WuXi STA, a China-based pharmaceutical company, launched parenteral formulation manufacturing line. The new parenteral formulation manufacturing line, along with the sterile manufacturing plant located in Wuxi, is designed in accordance with cGMP requirements set by the U.S. FDA, EMA, and China NMPA. It features the latest generation of isolation systems and filling machines in the industry. The entire filling process is carried out by robotics within a fully isolated environment, which is specifically designed to reduce human intervention and eliminate contamination, thereby ensuring high product quality.
How do regional factors impact the small volume parenteral market, and which region is the largest contributor?
North America was the largest region in the small volume parenteral market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the small volume parenteral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Does The Small Volume Parenteral Market Report 2025 Offer?
The small volume parenteral market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Small volume parenteral (SVP) refers to a category of sterile drug products that are intended for parenteral administration (bypassing the gastrointestinal tract) and are typically provided in volumes of 100 milliliters (mL) or less. These products are used for various medical purposes, including delivering medications, vaccines, or biological treatments directly into the body via intravenous (IV), intramuscular (IM), or subcutaneous (SC) routes.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15925
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
